by Dan Roberts August 2001 Background On The Research Stem cells are undeveloped structures which are able develop into any of the nearly 220 cell types that make up the human body, and which can theoretically reproduce themselves infinitely. Recent discovery of adult stem cells, or progenitor cells, in the eyes of adult rodents has [Read More]
Phase II Clinical Trial to Begin This Year StemCells, Inc. yesterday announced that, based on positive interim results, it has closed enrollment in its Phase I/II clinical trial for dry age-related macular degeneration (AMD) in order to focus its efforts on a follow-on Phase II randomized, controlled proof-of-concept study. Exceeding the company’s expectations, interim results showed [Read More]
by Dan Roberts Updated March 30, 2015 A means of delivering drugs into the retina on a time release basis is being developed and proven safe and effective. It is achieved by a method called Encapsulated Cell Technology (ECT), being tested by Neurotech SA with support from the National Eye Institute (NEI), Bethesda, Maryland. A [Read More]
by Dan Roberts Table of Contents About the Author I’m Visually Impaired, But . . . Twenty Things Eye Doctors Probably Don’t Tell You (But Would Like You To Know) Catching The Big One Correcting Misconceptions About AMD Detours Every Patient Can Be an Advocate Former Driver, Retired With Honor Hidden Disabilities: A Social Dilemma [Read More]
